Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01945775 |
|---|---|
| Brief Title: | A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) (EMBRACA) |
| First Submitted : | September 11, 2013 |
| First Submitted that Met QC Criteria : | September 16, 2013 |
| First Posted : | September 19, 2013 (Estimate) |
| Results First Submitted : | September 5, 2018 |
| Results First Submitted that Met QC Criteria : | September 5, 2018 |
| Results First Posted : | October 3, 2018 |
| Last Update Submitted that Met QC Criteria : | December 20, 2021 |
| Last Update Posted : | January 20, 2022 |